MKI67 and neoplasm: We wanted to know how frequently and to what degree HER2, ER, PR, and Ki-67 status changed after surgery (especially in the subset that received neoadjuvant therapy), and whether such changes were linked with patient age, tumor histologic grade, and treatment type.